IndraLab

Statements


OTUD7B inhibits NFKB1. 1 / 1
| 1

reach
"Of the targets shown in Fig. 1, an inhibitor of the deubiquitinase enzyme (DUB), OTUD7B, could specifically activate the non-canonical NFkB pathway."